GENETIC MODIFIERS OF SICKLE CELL DISEASE

被引:21
|
作者
Thein, Swee Lay [1 ,2 ]
机构
[1] Kings Coll London, Dept Mol Haematol, James Black Ctr, London SE5 9NU, England
[2] Kings Coll Hosp Natl Hlth Serv Fdn Trust, Dept Haematol Med, London, England
关键词
Sickle cell disease; Genetic association studies; Genome-wide association studies (GWAS); FETAL-HEMOGLOBIN PRODUCTION; QUANTITATIVE-TRAIT LOCUS; GENOME-WIDE ASSOCIATION; FACTOR KLF1 CAUSES; ALPHA-THALASSEMIA; TRANSCRIPTION FACTOR; RISK-FACTOR; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; PROMOTER POLYMORPHISMS; BETA-THALASSEMIA;
D O I
10.3109/03630269.2011.615876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sickle cell disease is one of the best characterized human monogenic disorders. Complex genotype/phenotype correlations clearly demonstrate the interaction of multiple genetic and environmental factors. In the last 20 years, scientific research has applied genetic approaches to dissect some of these modifiers. This review highlights the more recent genetic association studies that have been applied to unravel the genetic modifiers of sickle cell disease including Hb F genetics, and the key genetic variants identified. Illumination of such modifying factors may guide future therapeutic interventions and improve prediction of disease severity, with implications for genetic counseling, prenatal diagnosis and implementation of high risk therapy.
引用
收藏
页码:589 / 606
页数:18
相关论文
共 50 条
  • [41] Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island
    Muszlak, Mathias
    Pissard, Serge
    Badens, Catherine
    Chamouine, Abdourahim
    Maillard, Olivier
    Thuret, Isabelle
    HEMOGLOBIN, 2015, 39 (03) : 156 - 161
  • [42] Genetic Variation and Sickle Cell Disease Severity
    Kirkham, Justin K.
    Estepp, Jeremie H.
    Weiss, Mitch J.
    Rashkin, Sara R.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2337484
  • [43] The promise of genetic therapies in sickle cell disease
    不详
    LANCET, 2023, 402 (10419): : 2265 - 2265
  • [44] Emerging Genetic Therapy for Sickle Cell Disease
    Orkin, Stuart H.
    Bauer, Daniel E.
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 257 - 271
  • [45] Genetic admixture in sickle cell disease Response
    Solovieff, Nadia
    Steinberg, Martin H.
    Sebastiani, Paola
    BLOOD, 2011, 118 (16) : 4495 - 4495
  • [46] Pklr Is a Genetic Modifier of Sickle Cell Disease
    Wang, Xunde
    Tegegn, Mickias
    Seifuddin, Fayaz
    Menzel, Stephan
    Patel, Hamel
    Fu, Yi-Ping
    Jeffries, Neal
    Pirooznia, Mehdi
    Gardner, Kate
    Thein, Swee Lay
    BLOOD, 2021, 138
  • [47] A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia
    Adeyemo, Titilope A.
    Ojewunmi, Oyesola O.
    Oyetunji, Idat A.
    Rooks, Helen
    Rees, David C.
    Akinsulie, Adebola O.
    Akanmu, Alani S.
    Thein, Swee Lay
    Menzel, Stephan
    PLOS ONE, 2018, 13 (06):
  • [48] Sickle cell anemia - Nitric oxide related genetic modifiers of hematological and biochemical parameters
    Aguiar, Laura
    Matos, Andreia
    Gil, Angela
    Afonso, Conceicao
    Almeida, Salome
    Braga, Ligia
    Lavinha, Joao
    Kjollerstrom, Paula
    Faustino, Paula
    Bicho, Manuel
    Inacio, Angela
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2016, 64 (04) : 957 - 963
  • [49] A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease
    Liu, Li
    Pertsemlidis, Alexander
    Ding, Liang-Hao
    Story, Michael D.
    Steinberg, Martin H.
    Sebastiani, Paola
    Hoppe, Carolyn
    Ballas, Samir K.
    Pace, Betty S.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (07) : 706 - 718
  • [50] Genetic modifiers of sickle cell disease: Endothelin-1 as a candidate gene and validation of a new SNP discovery assay.
    Keller, M
    Schmidt, R
    Trottnow, T
    Ponte, C
    Schmidt, L
    Reilly, A
    Ballas, S
    Sandler, E
    Surrey, S
    Schwartz, E
    BLOOD, 2000, 96 (11) : 18B - 18B